Bicalutamide,Goserelin acetate,Leuprolide acetate
Astrazeneca,tolmar,sanofi,recordati
['prostate', 'radicals-hd', 'pcsm']
first results from the radicals-hd trial demonstrated improved metastasis-free survival with 2 years of androgen-deprivation therapy (adt) plus radiotherapy in men with prostate cancer. #pcsm #esmo22 | 
Home of the journal ONCOLOGY®, CancerNetwork® offers different perspectives on oncology/hematology through review articles, news, podcasts, blogs, and more.